Novel usage of the cryoballoon catheter to achieve large area atrial substrate modification in persistent and long-standing persistent atrial fibrillation

Journal of Interventional Cardiac Electrophysiology

Volumn 46, Issue 3, 2016, Pages 275-285

  Su, Wilber W ^a   Alzubaidi, Muhanad ^a   Tseng, Roger ^a   Jebaily, Nicholas ^a   Lin, Yenn Jiang ^b   Wang, Paul J ^c  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmia; Atrial fibrillation; Cryoablation; Cryoballoon; Pulmonary vein isolation

Indexed keywords

ABLATION THERAPY; ADULT; ARTICLE; BALLOON CATHETER; CLINICAL EFFECTIVENESS; CRYOBALLOON CATHETER; FALSE ANEURYSM; FLUOROSCOPY; HEART TAMPONADE; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; NERVE INJURY; PAROXYSMAL ATRIAL FIBRILLATION; PATIENT SAFETY; PERSISTENT ATRIAL FIBRILLATION; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; TREATMENT OUTCOME; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; CHRONIC DISEASE; CRYOTHERAPY; DEVICE FAILURE ANALYSIS; DEVICES; EQUIPMENT DESIGN; FEMALE; MALE; MIDDLE AGED; OPERATION DURATION; PREVALENCE; PROCEDURES; PULMONARY VEIN; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CATHETER ABLATION; CHRONIC DISEASE; CRYOTHERAPY; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPERATIVE TIME; PREVALENCE; PULMONARY VEINS; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84959502056     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-016-0120-y     Document Type: Article

References (27)

1. Calkins, H., Kuck, K. H., Cappato, R., et al. (2012). Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm, 9, 632–696.e21.
2. Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Le Mouroux, A., Le Métayer, P., & Clémenty, J. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New England Journal of Medicine, 339, 659–666.
3. Packer, D. L., Kowal, R. C., Wheelan, K. R., Irwin, J. M., Champagne, J., Guerra, P. G., Dubuc, M., Reddy, V., Nelson, L., Holcomb, R. G., Lehmann, J. W., Ruskin, J. N., & STOP AF Cryoablation Investigators. (2013). Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. Journal of the American College of Cardiology, 61, 1713–1723.
4. Schmidt, M., Dorwarth, U., Andresen, D., Brachmann, J., Kuck, K. H., Kuniss, M., Lewalter, T., Spitzer, S., Willems, S., Senges, J., Jünger, C., & Hoffmann, E. (2014). Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry. Journal of Cardiovascular Electrophysiology, 25, 1–7.
5. Straube, F., Dorwarth, U., Vogt, J., et al. (2014). Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy. Europace, 16, 1434–1442.
6. Reddy, V. Y., Sediva, L., Petru, J., Skoda, J., Chovanec, M., Chitovova, Z., DI Stefano, P., Rubin, E., Dukkipati, S., & Neuzil, P. (2015). Durability of pulmonary vein isolation with cryoballoon ablation: results from the SU stained PV isolation with ARctic front advance (SUPIR) study. Journal of Cardiovascular Electrophysiology, 26, 493–500.
7. Bordignon, S., Fürnkranz, A., Perrotta, L., Dugo, D., Konstantinou, A., Nowak, B., Schulte-Hahn, B., Schmidt, B., & Chun, K. R. (2015). High rate of durable pulmonary vein isolation after second-generation cryoballoon ablation: analysis of repeat procedures. Europace, 17, 725–1731.
8. Juliá, J., Chierchia, G. B., de Asmundis, C., et al. (2015). Regular atrial tachycardias following pulmonary vein isolation for paroxysmal atrial fibrillation: a retrospective comparison between the cryoballoon and conventional focal tip radiofrequency techniques. Journal of Interventional Cardiac Electrophysiology, 42, 161–169.
9. Kenigsberg, D. N., Martin, N., Lim, H. W., Kowalski, M., & Ellenbogen, K. A. (2015). Quantification of the cryoablation zone demarcated by pre- and postprocedural electroanatomic mapping in patients with atrial fibrillation using the 28-mm second-generation cryoballoon. Heart Rhythm, 12, 283–290.
10. Pajitnev, D., Neumann, T., Greiss, H., Zaltsberg, S., Akkaya, E., Deubner, N., Berkowitsch, A., Hamm, C., Kuniss M. (2014). Creating left atrial roof line using arctic front advance cryoballoon in patient with persistent atrial fibrillation: a safety and feasibility study. Cardiostim. Conference abstract.
11. Torbey, E., Parikh, V., Agarwal, V., Bekheit, S., Kowalski, M. (2014). Treatment of long persistent atrial fibrillation by single cryoballoon ablation of the pulmonary veins, LA roof line and ablation of left lateral ridge from within the appendage. Heart Rhythm Society. Conference abstract.
12. Frazier, D. W., Barrett, K. G. (2015). Linear lesions with Medtronic cryoballoon—posterior left atrial wall isolation. AF Symposium. Conference abstract.
13. Su, W., Kowal, R., Kowalski, M., Metzner, A., Svinarich, J. T., Wheelan, K., & Wang, P. (2015). Best practice guide for cryoballoon ablation in atrial fibrillation: the compilation experience of more than 3000 procedures. Heart Rhythm, 12, 1658–1666.
14. Fürnkranz, A., Bordignon, S., Schmidt, B., Böhmig, M., Böhmer, M. C., Bode, F., Schulte-Hahn, B., Nowak, B., Dignaß, A. U., & Chun, J. K. (2013). Luminal esophageal temperature predicts esophageal lesions after second-generation cryoballoon pulmonary vein isolation. Heart Rhythm, 10, 789–793.
15. Metzner, A., et al. (2013). Increased incidence of esophageal thermal lesions using the second-generation 28-mm cryoballoon. Circulation. Arrhythmia and Electrophysiology, 6, 769–775.
16. Chun, K. R., Schmidt, B., Metzner, A., Tilz, R., Zerm, T., Köster, I., Fürnkranz, A., Koektuerk, B., Konstantinidou, M., Antz, M., Ouyang, F., & Kuck, K. H. (2009). The ‘single big cryoballoon’ technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. European Heart Journal, 30, 699–709.
17. Aryana, A., Morkoch, S., Bailey, S., Lim, H. W., Sara, R., d’Avila, A., & O’Neill, P. G. (2014). Acute procedural and cryoballoon characteristics from cryoablation of atrial fibrillation using the first- and second-generation cryoballoon: a retrospective comparative study with follow-up outcomes. Journal of Interventional Cardiac Electrophysiology, 41, 177–1786.
18. Chierchia, G. B., Di Giovanni, G., Ciconte, G., et al. (2014). Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up. Europace, 16, 639–644.
19. Di Giovanni, G., Wauters, K., Chierchia, G. B., et al. (2014). One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon. Journal of Cardiovascular Electrophysiology, 25, 834–839.
20. Fürnkranz, A., Bordignon, S., Dugo, D., Perotta, L., Gunawardene, M., Schulte-Hahn, B., Nowak, B., Schmidt, B., & Chun, J. K. (2014). Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. Journal of Cardiovascular Electrophysiology, 25, 840–844.
21. Kumar, N., Blaauw, Y., Timmermans, C., Pison, L., Vernooy, K., & Crijns, H. (2014). Adenosine testing after second-generation balloon devices (cryothermal and laser) mediated pulmonary vein ablation for atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 41, 91–97.
22. Metzner, A., Reissmann, B., Rausch, P., et al. (2014). One-year clinical outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Circulation. Arrhythmia and Electrophysiology, 7, 288–292.
23. Aytemir, K., Gurses, K. M., Yalcin, M. U., Kocyigit, D., Dural, M., Evranos, B., Yorgun, H., Ates, A. H., Sahiner, M. L., Kaya, E. B., & Oto, M. A. (2015). Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second-generation cryoballoon. Europace, 17, 379–387.
24. Jourda, F., Providencia, R., Marijon, E., Bouzeman, A., Hireche, H., Khoueiry, Z., Cardin, C., Combes, N., Combes, S., Boveda, S., & Albenque, J. P. (2015). Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation. Europace, 17, 225–231.
25. Verma, A., Jiang, C. Y., Betts, T. R., STAR AF II Investigators, et al. (2015). Approaches to catheter ablation for persistent atrial fibrillation. New England Journal of Medicine, 372, 1812–1822.
26. Winkle, R. A. (2015). How much ablation to eliminate atrial fibrillation: is less more or is more more? Heart Rhythm.
27. Latchamsetty, R., & Morady, F. (2014). Catheter ablation of atrial fibrillation. Cardiology Clinics, 32, 551–561.